Discover the causes of erectile dysfunction and explore how non-invasive shockwave therapy can be an effective treatment ...
Resurge Therapeutics, a clinical-stage urology company, today announced positive clinical results from two studies evaluating its proprietary IntraProstatic Drug Elution (IPDE) therapy. The IPDE ...
Telix to partner with companies developing advanced minimally invasive and image-guided ablative technologies for prostate cancer.Initial focus ...
Hosted on MSN
ED treatments that actually work for you
Why ED happens: ED can stem from hormonal, cardiovascular, neurological, or psychological causes, and even cancer treatments can impact sexual health. Medication options: PDE5 inhibitors like Viagra ...
PROCEPT BioRobotics Corporation ( PRCT) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT Stephanie Piazzola, I cover medical devices at BofA. And next up, we have PROCEPT ...
Chronic PDE-5 inhibitor therapy is linked to a lower hazard of open-angle glaucoma and glaucoma suspect status, a large cohort study finds.
The partners will incorporate Telix's PSMA-PET gallium 68-based imaging agents Gozellix and Illuccix with EDAP and Profound's technologies for minimally invasive treatment.
Peptide injections are booming across San Antonio wellness clinics and med spas, but many lack FDA approval and strong safety data.
The Veterans’ Affairs Administration pulled the plug this month on a Biden-era initiative to supply vibrators to female vets.
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results